Technicals

Can the Rally in Gentherm (THRM) Shares Continue? – Tale of the Tape

Gentherm Inc ( THRM ) has been on the move lately as the stock has risen by 22.6% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue? While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on THRM is moving in the right direction. […]

Mergers & Acquisitions

Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine

Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine – Potentially first biomarker-guided schizophrenia therapeutic – Novel mechanism of action with improved safety profile – Denovo’s second late-stage asset acquired in the past 6 months PR Newswire SAN DIEGO, March 3, 2015 SAN DIEGO , March 3, 2015 /PRNewswire/ — Denovo Biopharma, LLC, today announced that it has exclusively licensed Pomaglumetad Methionil (mGlu2/3 receptor agonist), a late-stage neuroscience drug, from Eli Lilly and Company (NYSE: LLY). Denovo gains all rights to develop, manufacture and commercialize pomaglumetad globally, including transfer of all intellectual property and other rights, data, and information. Lilly has an option to re-acquire pomaglumetad upon a successful clinical trial, for predetermined undisclosed financial terms. […]

Mergers & Acquisitions

Platts Acquires Germany’s Minerals Value Service (MVS)

Platts Acquires Germany’s Minerals Value Service (MVS) Platts Purchases Remaining Stake in Company Providing “Value-in-Use” Analytics for Iron Ore PR Newswire LONDON, March 3, 2015 LONDON , March 3, 2015 /PRNewswire/ — Platts, a leading global energy, metals, petrochemicals and agriculture information provider, announced today that it has acquired Munich -based Minerals Value Service GmbH (MVS), a privately held company specialising in determining value-in-use for miners, mills and traders in the iron ore and steelmaking industries. The purchase extends a partnership launched in October 2013 under which Platts took an equity stake in MVS and became the exclusive distributor of MVS’ web-based value-in-use tool , which enables users to calculate a value of iron ore for specific buying and selling scenarios. “Over the course of our partnership with MVS, the value of this unique analytical tool has become increasingly apparent,” said Andrew Goodwin , Platts general manager, metals […]

Mergers & Acquisitions

European Capital Arranges Unitranche Financing to Support the Acquisition of sofa.com by CBPE Capital

European Capital Arranges Unitranche Financing to Support the Acquisition of sofa.com by CBPE Capital PR Newswire LONDON, March 3, 2015 LONDON , March 3, 2015 /PRNewswire/ — European Capital UK SME Debt fund, together with European Capital Limited and its subsidiaries (“European Capital”), has arranged the unitranche financing supporting CBPE Capital’s (“CBPE”) acquisition of sofa.com (the “Company”). “We are extremely pleased to provide financing for the acquisition of sofa.com, which will support its plans for future development in the UK,” said Jerry Tebbutt , Managing Director. […]

Mergers & Acquisitions

Lord Browne Appointed Head of DEA’s Supervisory Board

Lord Browne Appointed Head of DEA’s Supervisory Board PR Newswire HAMBURG, Germany, March 3, 2015 HAMBURG, Germany , March 3, 2015 /PRNewswire/ — – German upstream company turns into platform for growth – Cross reference: Picture is available at epa european pressphoto agency ( http://www.epa.eu ) and http://www.presseportal.de/pm/116249/ After the acquisition by LetterOne, the Hamburg based upstream company RWE Dea has a new owner, a new supervisory board and gets a new name. LetterOne is a privately owned Luxembourg -based global investment vehicle focused on utilizing its financial resources, management and investment expertise. […]

Peter Schiff

Nasdaq 5000: Bubble or not?

[youtube f7IMN0eTVT8] Peter Schiff on CNBC 3/2/2015 Sign up for my free newsletter: http://www.europac.net/subscribe_free_reports Buy my newest book at http://www.tinyurl.com/RealCrash Friend me on http://www.Facebook.com/PeterSchiff Follow me on http://www.Twitter.com/PeterSchiff […]

Mergers & Acquisitions

Aegon Completes Sale of Equity Stake in La Mondiale Participations

Aegon Completes Sale of Equity Stake in La Mondiale Participations PR Newswire THE HAGUE, The Netherlands, March 3, 2015 THE HAGUE, The Netherlands , March 3, 2015 /PRNewswire/ — Aegon has completed the sale of its 35% share in La Mondiale Participations following the granting of approval by the French Competition Authority (Autorit de la Concurrence). The agreement to sell Aegon’s stake in La Mondiale Participations to La Mondiale for EUR 350 million was announced on November 24, 2014 . […]

Mergers & Acquisitions

Prime Healthcare Continues Growth with Completed Acquisitions of Dallas Regional Medical Center in Texas and Riverview Regional Medical Center in Alabama

Prime Healthcare Continues Growth with Completed Acquisitions of Dallas Regional Medical Center in Texas and Riverview Regional Medical Center in Alabama PR Newswire ONTARIO, Calif., March 2, 2015 ONTARIO, Calif. , March 2, 2015 /PRNewswire/ — Prime Healthcare announced today that it has completed its acquisition of two hospitals from subsidiaries of Community Health Systems: Dallas Regional Medical Center in Mesquite, Texas and Riverview Regional Medical Center in Gadsden, Alabama , as well as related outpatient services. “Prime Healthcare looks forward to continuing extraordinary care at both Dallas Regional and Riverview Regional,” said Prem Reddy , MD, FACC, FCCP, Chairman, President and CEO of Prime Healthcare Services […]

Stock Analysts

Roche’s Avastin Gets Positive Opinion for Cervical Cancer

Positive news flowed in for Roche RHHBY when the European Union’s (EU) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on the use of Avastin in combination with standard chemotherapy (paclitaxel and cisplatin or paclitaxel and topotecan in patients who cannot receive platinum therapy) for the treatment of adult patients with persistent, recurrent or metastatic carcinoma of the cervix. As per the European Cancer Observatory, it is estimated that approximately 33,000 new cases of cervical cancer will be diagnosed in the EU in 2015, with expected death of 13,000. We note that Avastin had been approved in Aug 2014 in the U.S. […]